Goodman Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-65
| Closed | -$5.45K | – | 96 |
|
|
2024
Q3 | $5.45K | Buy |
+65
| New | +$5.45K | ﹤0.01% | 167 |
|
|
2024
Q2 | – | Sell |
-68,144
| Closed | -$4.99M | – | 189 |
|
|
2024
Q1 | $4.99M | Sell |
68,144
-9,771
| -13% | -$716K | 1.58% | 23 |
|
|
2023
Q4 | $6.31M | Sell |
77,915
-17,821
| -19% | -$1.44M | 2.15% | 13 |
|
|
2023
Q3 | $7.17M | Sell |
95,736
-9,599
| -9% | -$719K | 2.68% | 9 |
|
|
2023
Q2 | $8.12M | Sell |
105,335
-3,496
| -3% | -$269K | 3.01% | 7 |
|
|
2023
Q1 | $9.03M | Buy |
108,831
+46,240
| +74% | +$3.84M | 4.92% | 6 |
|
|
2022
Q4 | $5.37M | Buy |
62,591
+5,267
| +9% | +$452K | 3.13% | 9 |
|
|
2022
Q3 | $3.54M | Buy |
57,324
+36,382
| +174% | +$2.24M | 1.93% | 11 |
|
|
2022
Q2 | $1.29M | Buy |
+20,942
| New | +$1.29M | 0.58% | 23 |
|